Irvine, California 92618, United States
Frank L. Jaksch, Kevin Farr, Rob Fried, Ben Shichman, Mark Friedman
1999
200
Private company
NASDAQ:CDXC
81.7
Genomic instability, Altered intercellular communication
Covid19
supplement
Phase 2 Trials
We are a global bioscience company dedicated to healthy aging.
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio.
Our team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age.